Properties of Pro‐Inflammatory Cell Type‐Specific Leukocyte Chemotactic Cytokines, Interleukin 8 (IL‐8) and Monocyte Chemotactic and Activating Factor (MCAF)

Inflammation is a host defensive reaction to tissue injuries caused by various conditions such as trauma, infections, invasion of foreign particles, ischemia-reperfusion syndrome, malignant tumors, and autoimmune diseases. The early reactions of inflammations consist of plasma leakage and leukocyte infiltration into the lesion. The types of infiltrating leukocytes depend upon the kind, degree, and timing of tissue injuries. Although several factors such as C5a, leukotriene B4 and bacteriaderived formyl peptides have been long known as leukocyte chemotactic factors, these factors chemoattract any kind of leukocytes, thus suggesting the existence of cell type-specific leukocyte chemotactic factors (28). Over the past several years, numerous members of a new family of heparinbinding polypeptide cytokines with a molecular weight of 8-10 kDa have been identified (Ref. 25) (Table 1) . These factors have 4 cysteine residues at the wellconserved positions and are presumed to possess a similar structure (25). These cytokines are produced massively and rapidly by various kinds of cells in response to inflammatory stimuli including lipopolysaccharide (LPS) , viruses, interleukin 1 (IL-1), tumor necrosis factor (TNF) and so on [Tables 2 and 3 show the cell sources and inducers of interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF) described below]. Furthermore, it has become evident that several of these cytokines have chemotactic activity for specific type(s) of leukocytes, suggesting that these factors are bona fide chemoattractants involved in the leukocyte recruitment seen in the inflammatory processes. These factors are subdivided into two subgroups depending on whether the first two cysteines are separated by a single amino acid or in an adjacent position (Table 1). The former are called intercrine

[1]  K. Matsushima,et al.  Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. , 1992, Immunology.

[2]  W. Wood,et al.  Characterization of complementary DNA clones encoding the rabbit IL-8 receptor. , 1992, Journal of immunology.

[3]  R. Crystal,et al.  Interleukin-8 gene expression in human bronchial epithelial cells. , 1991, The Journal of biological chemistry.

[4]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[5]  A. Mantovani,et al.  The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.

[6]  P. Murphy,et al.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.

[7]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[8]  S. Murakami,et al.  Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.

[9]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Matsushima,et al.  1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. , 1991, Biochemical and biophysical research communications.

[11]  K. Matsushima,et al.  Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. , 1991, Journal of immunology.

[12]  A. Gronenborn,et al.  Crystal structure of interleukin 8: symbiosis of NMR and crystallography. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[14]  E. Leonard,et al.  Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.

[15]  K. Matsushima,et al.  IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. , 1991, Immunology.

[16]  A. Gronenborn,et al.  Three-dimensional structure of interleukin 8 in solution. , 1991, Biochemistry.

[17]  K. Matsushima,et al.  Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. , 1990, The Journal of biological chemistry.

[18]  A. J. Valente,et al.  Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells. , 1990, The Journal of biological chemistry.

[19]  T. Standiford,et al.  IL-4 inhibits the expression of IL-8 from stimulated human monocytes. , 1990, Journal of immunology.

[20]  E. Leonard,et al.  Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. , 1990, Journal of immunology.

[21]  A. J. Valente,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Appella,et al.  Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line , 1990, The Journal of experimental medicine.

[23]  C. Homon,et al.  Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. , 1990, The Journal of biological chemistry.

[24]  A. Sica,et al.  Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. , 1990, Journal of immunology.

[25]  D. Baltimore,et al.  Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" , 1990, Nature.

[26]  M. Baggiolini,et al.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils , 1990, The Journal of experimental medicine.

[27]  D. Blanchard,et al.  Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. , 1990, Journal of immunology.

[28]  H. Th. Marc Timmers,et al.  Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction , 1990, Nucleic Acids Res..

[29]  K. Matsushima,et al.  Enhanced phosphorylation of 65 and 74 kDa proteins by tumor necrosis factor and interleukin-1 in human peripheral blood mononuclear cells. , 1990, Cytokine.

[30]  A. Cerami,et al.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  B. Rollins,et al.  The human homolog of the JE gene encodes a monocyte secretory protein , 1989, Molecular and cellular biology.

[32]  J. Besemer,et al.  Specific binding, internalization, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes. , 1989, The Journal of biological chemistry.

[33]  K. Matsushima,et al.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. , 1989, Journal of immunology.

[34]  M. Kaliner,et al.  Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. , 1989, Immunology letters.

[35]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .

[36]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[37]  E. Appella,et al.  Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. , 1989, Journal of immunology.

[38]  K. Matsushima,et al.  Brief Definitive Report Identification and Characterization of Specific Receptors for Monocyte-derived Neutrophil Chemotactic Factor (mdncf) on Human Neutrophils , 2022 .

[39]  M. Yamada,et al.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.

[40]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[41]  E. Appella,et al.  Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. , 1989, Molecular immunology.

[42]  M. Baggiolini,et al.  Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[44]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Ryan The origin and sequence of the cells found in the acute inflammatory response. , 1967, The Australian journal of experimental biology and medical science.